FDA-approved ADHD brain device fails to outperform placebo
The first-of-a-kind brain-stimulation device approved to treat attention-deficit/hyperactivity disorder (ADHD) in the US has had its efficacy questioned, with scientists believing that its Food and Drug Administration (US) approval was based on too small a study.
Category: ADHD & Autism, Brain Health, Body and Mind
Tags: King's College London, ADHD, Developmental conditions, Brain stimulation, Nerves, clinical trials, University of Southampton
